Fibrocartilaginous embolism is a rare vascular cause of spinal cord infarction in which nucleus pulposus or intervertebral disc fibrocartilage embolizes to spinal vessels, often after axial loading, exertion, or minor trauma. The resulting central or spinal arterial occlusion produces acute ischemic myelopathy with sudden back or neck pain, weakness or paralysis, and sensory or autonomic deficits.
Ask a research question about Fibrocartilaginous Embolism. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Fibrocartilaginous Embolism
creation_date: "2026-05-05T11:41:54Z"
updated_date: "2026-05-05T11:41:54Z"
description: >-
Fibrocartilaginous embolism is a rare vascular cause of spinal cord
infarction in which nucleus pulposus or intervertebral disc fibrocartilage
embolizes to spinal vessels, often after axial loading, exertion, or minor
trauma. The resulting central or spinal arterial occlusion produces acute
ischemic myelopathy with sudden back or neck pain, weakness or paralysis, and
sensory or autonomic deficits.
category: Complex
disease_term:
preferred_term: fibrocartilaginous embolism
term:
id: MONDO:0023152
label: fibrocartilaginous embolism
parents:
- Vascular disorder
synonyms:
- Fibrocartilaginous embolic myelopathy
pathophysiology:
- name: Pressure-related intervertebral disc injury
description: >-
Axial loading, Valsalva-like maneuvers, or related pressure events can
acutely increase intradiscal pressure and initiate nucleus pulposus
displacement.
locations:
- preferred_term: intervertebral disk
term:
id: UBERON:0001066
label: intervertebral disk
downstream:
- target: Nucleus pulposus fibrocartilage embolization
description: Pressure-related disc injury can introduce nucleus pulposus material into spinal vasculature.
evidence:
- reference: PMID:14970983
reference_title: "Fibrocartilaginous embolism--an uncommon cause of spinal cord infarction: a case report and review of the literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
An increased intradiskal pressure resulting from axial loading of the vertebral column with a concomitant Valsalva maneuver is thought to be the initiating event for the embolus.
explanation: This supports axial loading and Valsalva-related intradiscal pressure as the initiating event.
- name: Nucleus pulposus fibrocartilage embolization
description: >-
Acute vertical disc herniation can introduce nucleus pulposus
fibrocartilage into spinal vasculature, with retrograde embolization to a
central or spinal artery.
locations:
- preferred_term: intervertebral disk
term:
id: UBERON:0001066
label: intervertebral disk
- preferred_term: anterior spinal artery
term:
id: UBERON:0005431
label: anterior spinal artery
downstream:
- target: Spinal cord infarction
description: Fibrocartilaginous embolic occlusion obstructs spinal cord blood flow and causes ischemic infarction.
evidence:
- reference: PMID:14970983
reference_title: "Fibrocartilaginous embolism--an uncommon cause of spinal cord infarction: a case report and review of the literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
It is postulated that an acute vertical disk herniation of the nucleus pulposus material can lead to spinal cord infarction by a retrograde embolization to the central artery.
explanation: This review/case report states the proposed nucleus pulposus embolization mechanism.
- reference: DOI:10.1177/0883073809355822
reference_title: "Spinal Cord Infarction Due to Fibrocartilaginous Embolization: The Role of Diffusion Weighted Imaging and Short-Tau Inversion Recovery Sequences"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Fibrocartilaginous embolization is a rare cause of ischemic myelopathy caused by embolization of intersomatic disk nucleus pulposus into spinal vasculature during Valsalva-like maneuvers.
explanation: This independently supports nucleus pulposus embolization into spinal vasculature.
- name: Spinal cord infarction
description: >-
Vascular occlusion by fibrocartilage causes spinal cord ischemia and
infarction, which can present as acute myelopathy and may be misdiagnosed as
inflammatory transverse myelitis.
cell_types:
- preferred_term: neuron
term:
id: CL:0000540
label: neuron
locations:
- preferred_term: spinal cord
term:
id: UBERON:0002240
label: spinal cord
biological_processes:
- preferred_term: response to hypoxia
modifier: INCREASED
term:
id: GO:0001666
label: response to hypoxia
downstream:
- target: Acute ischemic myelopathy
description: Spinal cord infarction injures motor, sensory, and autonomic tracts, producing abrupt myelopathic deficits.
evidence:
- reference: PMID:26833287
reference_title: "Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Fibrocartilaginous Embolism (FCE) has been reported to represent 5.5% of spinal cord infarctions.
explanation: This review identifies FCE as a cause of spinal cord infarction.
- reference: PMID:26833287
reference_title: "Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
FCE of the spinal cord, often mis-diagnosed as transverse myelitis, may be more common than presumed.
explanation: This supports spinal-cord FCE as an acute myelopathy mimic.
- name: Acute ischemic myelopathy
description: >-
Infarction of the spinal cord causes abrupt motor and sensory dysfunction,
often with severe back pain at onset and variable long-term neurological
recovery.
locations:
- preferred_term: spinal cord
term:
id: UBERON:0002240
label: spinal cord
evidence:
- reference: PMID:37873837
reference_title: "Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We present the case of an otherwise healthy 17-year-old student who experienced sudden onset of severe low-back pain amidst intensive physical training, which rapidly deteriorated to complete sensory-motor paralysis of his lower limbs.
explanation: This case/review supports sudden pain followed by severe sensory-motor myelopathy.
phenotypes:
- category: Neurological
name: Spinal cord infarction
diagnostic: true
description: Spinal cord infarction is the defining vascular injury caused by fibrocartilaginous embolization.
phenotype_term:
preferred_term: Spinal cord infarction
evidence:
- reference: PMID:26833287
reference_title: "Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Fibrocartilaginous Embolism (FCE) has been reported to represent 5.5% of spinal cord infarctions.
explanation: This supports spinal cord infarction as the core FCE lesion.
- category: Neurological
name: Acute myelopathy
diagnostic: true
description: Acute spinal cord dysfunction is the defining clinical presentation.
phenotype_term:
preferred_term: Acute myelopathy
evidence:
- reference: PMID:26833287
reference_title: "Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
FCE of the spinal cord, often mis-diagnosed as transverse myelitis, may be more common than presumed.
explanation: This supports acute myelopathy as the clinical syndrome frequently confused with transverse myelitis.
- category: Musculoskeletal
name: Back pain
description: Sudden severe back pain can occur near onset.
phenotype_term:
preferred_term: Back pain
term:
id: HP:0003418
label: Back pain
temporality: ACUTE
evidence:
- reference: PMID:37873837
reference_title: "Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We present the case of an otherwise healthy 17-year-old student who experienced sudden onset of severe low-back pain amidst intensive physical training, which rapidly deteriorated to complete sensory-motor paralysis of his lower limbs.
explanation: This directly supports sudden severe low-back pain at presentation.
- category: Neurological
name: Lower-limb paralysis
description: Spinal cord infarction can cause acute lower-limb motor paralysis.
phenotype_term:
preferred_term: Paraplegia
term:
id: HP:0010550
label: Paraplegia
evidence:
- reference: PMID:37873837
reference_title: "Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We present the case of an otherwise healthy 17-year-old student who experienced sudden onset of severe low-back pain amidst intensive physical training, which rapidly deteriorated to complete sensory-motor paralysis of his lower limbs.
explanation: This supports acute lower-limb sensory-motor paralysis.
- category: Neurological
name: Paraparesis
description: Progressive paraparesis can occur after exertion or axial loading.
phenotype_term:
preferred_term: Paraparesis
term:
id: HP:0002385
label: Paraparesis
evidence:
- reference: PMID:14970983
reference_title: "Fibrocartilaginous embolism--an uncommon cause of spinal cord infarction: a case report and review of the literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We present a previously healthy 16-year-old boy with sudden onset of back pain and progressive paraparesis within 36 hours after lifting exercises in a squat position.
explanation: This case/review supports progressive paraparesis after exertion.
- category: Neurological
name: Somatic sensory dysfunction
description: Acute spinal cord infarction can cause sensory deficits alongside motor paralysis.
phenotype_term:
preferred_term: Somatic sensory dysfunction
term:
id: HP:0003474
label: Somatic sensory dysfunction
evidence:
- reference: PMID:37873837
reference_title: "Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
complete sensory-motor paralysis of his lower limbs.
explanation: This directly supports sensory dysfunction as part of FCE-associated lower-limb sensory-motor paralysis.
- category: Genitourinary
name: Autonomic bladder or bowel dysfunction
description: Anterior spinal artery territory ischemia can injure lateral horn autonomic pathways, producing bowel or bladder dysfunction.
phenotype_term:
preferred_term: Urinary incontinence
term:
id: HP:0000020
label: Urinary incontinence
evidence:
- reference: PMID:37456462
reference_title: Incomplete Anterior Spinal Artery Syndrome Responsive to Intrathecal Baclofen.
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
fecal or urinary incontinence
explanation: This supports autonomic bladder or bowel dysfunction in anterior spinal artery ischemia, a downstream spinal cord infarction pattern relevant to FCE.
environmental:
- name: Axial loading or Valsalva-associated spinal pressure
description: >-
Activities that increase intradiscal pressure, such as axial loading with a
Valsalva maneuver or lifting exercises, can precipitate the embolic event.
presence: Positive
evidence:
- reference: PMID:14970983
reference_title: "Fibrocartilaginous embolism--an uncommon cause of spinal cord infarction: a case report and review of the literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
An increased intradiskal pressure resulting from axial loading of the vertebral column with a concomitant Valsalva maneuver is thought to be the initiating event for the embolus.
explanation: This supports axial loading with Valsalva as a precipitating physical context.
diagnosis:
- name: Clinico-radiologic diagnosis with exclusion of inflammatory mimics
description: >-
Diagnosis is usually clinical and radiologic because tissue confirmation is
uncommon; work-up excludes infectious, autoimmune, inflammatory, and
neoplastic causes and correlates the presentation with spinal cord
infarction.
results: >-
Sudden myelopathy with spinal cord infarction, plausible disc or exertional
trigger, and no better inflammatory, infectious, autoimmune, or neoplastic
explanation supports suspected FCE.
evidence:
- reference: PMID:14970983
reference_title: "Fibrocartilaginous embolism--an uncommon cause of spinal cord infarction: a case report and review of the literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Laboratory investigation showed no evidence of infectious, autoimmune, inflammatory, or neoplastic causes.
explanation: This supports exclusion of alternative causes in suspected FCE diagnosis.
- reference: PMID:26833287
reference_title: "Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The 41 tissue proven cases are summarized and a schematic approach to the clinical diagnosis of FCE, deducted from their clinical findings, is presented.
explanation: This supports a clinical diagnostic approach when histologic confirmation is unavailable.
- name: MRI-supported spinal cord infarction diagnosis
description: >-
MRI supports suspected fibrocartilaginous embolism by showing spinal cord
lesions consistent with infarction, including T2 hyperintensity and
diffusion-weighted evidence of cytotoxic edema.
results: >-
T2-hyperintense spinal cord lesions and diffusion-weighted imaging evidence
of ischemia support FCE when clinical history and exclusion work-up are
compatible.
evidence:
- reference: DOI:10.1177/0883073809355822
reference_title: "Spinal Cord Infarction Due to Fibrocartilaginous Embolization: The Role of Diffusion Weighted Imaging and Short-Tau Inversion Recovery Sequences"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Diagnostic criteria are based on patient’s clinical history, magnetic resonance evidence of T2-hyperintense spinal cord lesion, and exclusion of other causes of ischemic myelopathy.
explanation: This supports MRI-based diagnosis with exclusion of other ischemic myelopathy causes.
- reference: DOI:10.1177/0883073809355822
reference_title: "Spinal Cord Infarction Due to Fibrocartilaginous Embolization: The Role of Diffusion Weighted Imaging and Short-Tau Inversion Recovery Sequences"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
diffusion-weighted imaging sequences played a pivotal role showing the ischemic nature of spinal cord lesions.
explanation: This supports diffusion-weighted imaging as a useful MRI sequence for ischemic spinal cord lesions in FCE.
treatments:
- name: Supportive rehabilitation after ischemic myelopathy
description: >-
Treatment is mainly supportive, focused on acute assessment, prevention of
complications, and inpatient or outpatient rehabilitation to maximize
neurologic and functional recovery.
treatment_term:
preferred_term: supportive care
term:
id: MAXO:0000950
label: supportive care
evidence:
- reference: PMID:37873837
reference_title: "Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
He subsequently received inpatient rehabilitation treatment for four months, after which he was followed as an outpatient for a total period of 16 months.
explanation: This supports rehabilitation-centered management after suspected FCE ischemic myelopathy.
- name: IV methylprednisolone during initial infarction work-up
description: >-
IV methylprednisolone has been used during initial evaluation when the
differential includes inflammatory myelopathy, but this is case-level
management rather than proven disease-specific therapy.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: methylprednisolone
term:
id: NCIT:C647
label: Methylprednisolone
evidence:
- reference: PMID:37873837
reference_title: "Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
He was treated with IV Methylprednisolone and anticoagulation after the initial work-up suggested spinal cord infarction.
explanation: This supports reported use of IV methylprednisolone during initial suspected spinal cord infarction work-up.
- name: Anticoagulation during initial infarction work-up
description: >-
Anticoagulation has been used during initial management of suspected spinal
cord infarction in FCE, but evidence remains anecdotal and not
disease-specific.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: anticoagulant agent
term:
id: NCIT:C263
label: Anticoagulant Agent
evidence:
- reference: PMID:37873837
reference_title: "Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review."
supports: PARTIAL
evidence_source: HUMAN_CLINICAL
snippet: >-
He was treated with IV Methylprednisolone and anticoagulation after the initial work-up suggested spinal cord infarction.
explanation: This supports reported anticoagulation during initial suspected spinal cord infarction work-up.
Fibrocartilaginous embolism (FCE) is an ischemic myelopathy (spinal cord infarction) caused by embolization of fibrocartilaginous material, presumed to originate from the nucleus pulposus of the intervertebral disc, into vessels supplying the spinal cord. In clinical practice it is typically a diagnosis of exclusion because definitive confirmation is usually postmortem or via biopsy/histopathology. (cuello2014acutecervicalmyelopathy pages 1-2, taous2023spinalcordinfarction pages 1-2, abdelrazek2016fibrocartilaginousembolisma pages 5-6)
Within the retrieved full-text evidence, explicit ontology identifiers (OMIM, Orphanet, ICD-10/ICD-11, MeSH, MONDO) were not stated. Therefore, this report cannot provide validated identifier mappings from the present evidence set. (cuello2014acutecervicalmyelopathy pages 1-2, abdelrazek2016fibrocartilaginousembolisma pages 5-6)
Evidence is primarily: - Human clinical: case reports, systematic reviews, and SCI cohorts with FCE as a subgroup (cuello2014acutecervicalmyelopathy pages 1-2, castello2023spinalcordinfarction pages 1-2, mateen2011clinicallysuspectedfibrocartilaginous pages 6-7) - Veterinary clinical/pathology: naturally occurring FCEM in dogs/cats with histologic confirmation and MRI phenotype (risio2010fibrocartilaginousembolicmyelopathy pages 6-8, togawa2024outcomeinparaplegic pages 1-2) - Clinical registry/trial record: observational SCI cohort explicitly including FCE criteria (NCT04372758 chunk 1)
Mechanistic cause (current understanding): migration/embolization of nucleus pulposus–derived fibrocartilaginous material into spinal cord vasculature causing arterial occlusion and infarction. (taous2023spinalcordinfarction pages 1-2, abdelrazek2016fibrocartilaginousembolisma pages 5-6, abdelrazek2016fibrocartilaginousembolisma pages 1-2)
FCE often follows minor trauma or mechanical/pressure events that plausibly increase intradiscal or intra-vertebral pressure (e.g., heavy lifting, physical exertion, bending, Valsalva-like maneuvers). (mateen2011clinicallysuspectedfibrocartilaginous pages 2-3, zalewski2019characteristicsofspontaneous pages 3-4, abdelrazek2016fibrocartilaginousembolisma pages 5-6)
Quantitative examples: - In a Mayo clinically suspected FCE cohort, 7/9 (78%) had a precipitating event within 24 hours (motor vehicle accident, heavy lifting, exertion, bending). (mateen2011clinicallysuspectedfibrocartilaginous pages 2-3) - In spontaneous SCI more broadly, 33/133 (25%) reported a precipitating physical maneuver (e.g., lifting/Valsalva). (zalewski2019characteristicsofspontaneous pages 3-4)
Vascular risk factors: Many patients with spontaneous SCI have vascular risk factors, but FCE is considered particularly in patients with fewer traditional vascular risk factors and supportive disc/vertebral imaging changes; some proposed criteria exclude patients with >2 vascular risk factors. (mateen2011clinicallysuspectedfibrocartilaginous pages 7-8, zalewski2019characteristicsofspontaneous pages 1-2)
No protective genetic or environmental factors were identified in the retrieved evidence. (mateen2011clinicallysuspectedfibrocartilaginous pages 6-7, abdelrazek2016fibrocartilaginousembolisma pages 5-6)
No validated gene–environment interactions were identified for human FCE in the retrieved evidence. (abdelrazek2016fibrocartilaginousembolisma pages 5-6)
Typical presentation involves: - Acute back/neck pain followed by rapid neurological deficit (mateen2011clinicallysuspectedfibrocartilaginous pages 2-3, cuello2014acutecervicalmyelopathy pages 1-2) - Acute paresis/paralysis (paraparesis/paraplegia or quadriparesis/quadriplegia), often initially flaccid with hyporeflexia (alfarsi2023spinalcordinfarct pages 2-4, chukwudelunzu2025fibrocartilaginousembolismspinala pages 2-3) - Sensory level; commonly selective impairment of pain/temperature (spinothalamic) with relative dorsal column sparing in anterior spinal artery territory presentations (alfarsi2023spinalcordinfarct pages 2-4, zalewski2019characteristicsofspontaneous pages 3-4) - Autonomic dysfunction (neurogenic bladder/bowel) (alfarsi2023spinalcordinfarct pages 2-4)
Deficits typically progress over minutes to hours to a nadir and then stabilize; severe disability is common, but recovery varies depending on lesion extent and level and access to rehabilitation. (mateen2011clinicallysuspectedfibrocartilaginous pages 6-7, shah2018fibrocartilaginousemboliin pages 4-4)
Based on the above clinical features: - Acute pain: Back pain (HP:0003418); Neck pain (HP:0000467) - Motor deficits: Paraplegia (HP:0003401); Quadriplegia (HP:0003293); Muscle weakness (HP:0001324) - Sensory deficits: Loss of pain sensation (HP:0007012); Sensory level (HP:0033725) (term availability may vary across HPO releases) - Autonomic: Neurogenic bladder (HP:0000010); Urinary retention (HP:0000016)
(These HPO suggestions are ontology-mapping aids; the retrieved papers describe the phenotypes but do not provide HPO codes.) (alfarsi2023spinalcordinfarct pages 2-4, mateen2011clinicallysuspectedfibrocartilaginous pages 2-3, zalewski2019characteristicsofspontaneous pages 3-4)
No causal genes, pathogenic germline variants, or inherited pattern are supported by the retrieved evidence. Human FCE is primarily treated as a mechanical/vascular phenomenon rather than a monogenic disease. (abdelrazek2016fibrocartilaginousembolisma pages 5-6)
No transcriptomic/proteomic/metabolomic signatures specific to human FCE were identified in the retrieved evidence. (mateen2011clinicallysuspectedfibrocartilaginous pages 6-7)
The most consistently reported environmental/behavioral correlates are activities increasing spinal load/pressure, including heavy lifting and physical exertion, and other minor traumatic or Valsalva-like events. (mateen2011clinicallysuspectedfibrocartilaginous pages 2-3, zalewski2019characteristicsofspontaneous pages 3-4)
No infectious etiology is supported; infectious/inflammatory causes are part of the differential diagnosis to be excluded. (mateen2011clinicallysuspectedfibrocartilaginous pages 2-3, abdelrazek2016fibrocartilaginousembolisma pages 5-6)
Primary tissue affected is spinal cord gray/white matter; cell types implicated in ischemic injury include: - Spinal cord neuron populations (especially anterior horn motor neurons in ASA territory) (manara2010spinalcordinfarction pages 3-4) - Glial cells involved in infarct evolution (inferred from ischemic myelopathy context; not directly profiled here). (manara2010spinalcordinfarction pages 3-4)
Hyperacute/acute onset is characteristic. - Mayo suspected-FCE cohort: maximal deficits within <12 h in all cases (mateen2011clinicallysuspectedfibrocartilaginous pages 2-3) - Spontaneous SCI cohort: nadir within 12 h in 77% (zalewski2019characteristicsofspontaneous pages 1-2)
Often stabilizes after reaching nadir; longer-term course depends on infarct size/level and rehabilitation. (shah2018fibrocartilaginousemboliin pages 4-4)
Population incidence/prevalence for human FCE remains poorly defined; however, proportions within SCI cohorts are reported: - Mayo SCI cohort: 9/164 (5.5%; 95% CI 2.5–10.2%) clinically suspected FCE among acute spinal cord infarctions. (mateen2011clinicallysuspectedfibrocartilaginous pages 1-2) - 2023 single-center 41-patient SCI series: fibrocartilaginous embolism 14.6% (6 cases); etiology undetermined 29.3%. (castello2023spinalcordinfarction pages 1-2, castello2023spinalcordinfarction pages 5-7)
MRI spine (core test): - T2 patterns typical for SCI include “owl eyes” and “pencil-like” hyperintensity (SCI data; also leveraged in FCE suspicion). (zalewski2019characteristicsofspontaneous pages 3-4, zalewski2019characteristicsofspontaneous pages 1-2) - FCE case reports emphasize cord swelling and T2 hyperintensity, often without early enhancement; adjacent disc pathology or Schmorl nodes can support FCE mechanism. (yamaguchi2019fibrocartilaginousembolismof pages 5-8, alfarsi2023spinalcordinfarct pages 2-4)
Diffusion-weighted imaging (DWI/ADC): - Helps distinguish cytotoxic (ischemic) from vasogenic (inflammatory) edema; recommended for acute myelopathy workups. (manara2010spinalcordinfarction pages 3-4, manara2010spinalcordinfarction pages 4-5) - In spontaneous SCI cohort: DWI/ADC restriction in 19/29 (67%). (zalewski2019characteristicsofspontaneous pages 3-4)
CSF: usually normal or mild nonspecific abnormalities; used to exclude inflammation. - In spontaneous SCI: mild inflammation in 7/89 (8%) (elevated nucleated cells). (zalewski2019characteristicsofspontaneous pages 1-2)
Frequently confounded with inflammatory myelopathies (e.g., transverse myelitis) and other acute myelopathies; multiple reports note misdiagnosis risk and delay. (alfarsi2023spinalcordinfarct pages 2-4, zalewski2019characteristicsofspontaneous pages 1-2)
Definitive diagnosis is histopathologic identification of fibrocartilaginous material within spinal cord vessels (often autopsy). (risio2010fibrocartilaginousembolicmyelopathy pages 6-8, abdelrazek2016fibrocartilaginousembolisma pages 1-2)
Severity at onset and lesion extent influence recovery; SCI literature identifies older age, vascular risk factors, and anterior spinal artery watershed involvement as worse prognostic indicators. (mcbride2024nonsurgicalspinalcord pages 3-4)
Evidence does not support a specific proven acute therapy for FCE. - In Mayo suspected-FCE series, IV steroids, plasma exchange, IV heparin, IVIG, and decompressive surgery did not yield meaningful acute improvement. (mateen2011clinicallysuspectedfibrocartilaginous pages 6-7) - Some cases are treated with antiplatelet therapy (e.g., aspirin) after excluding inflammatory etiologies; this is largely extrapolated rather than evidence-based for FCE specifically. (alfarsi2023spinalcordinfarct pages 2-4, castello2023spinalcordinfarction pages 5-7)
A pediatric illustrative case applied continuous CSF drainage plus mean arterial pressure augmentation (permissive hypertension) and steroids with substantial neurological improvement; this is hypothesis-generating and extrapolated from aortic surgery spinal cord protection principles. (fedaravicius2021successfulmanagementof pages 1-2)
Rehabilitation is consistently emphasized. - Pediatric rehabilitation case literature reports substantial functional gains after intensive inpatient rehabilitation and advocates early initiation of comprehensive rehab. (shah2018fibrocartilaginousemboliin pages 4-4) - In an inpatient rehab cohort of probable FCEM (31 patients), functional scores improved (motor FIM increased from 36 to 69 during rehab), though many still used wheelchairs as primary mobility at discharge. (moore2018fibrocartilaginousembolicmyelopathy pages 1-2)
No validated primary prevention strategy exists because FCE is rare, unpredictable, and typically associated with nonspecific mechanical triggers. Practical prevention is therefore limited to general spine safety and vascular-risk management when appropriate, but this is not evidence-based for FCE prevention specifically in the retrieved literature. (abdelrazek2016fibrocartilaginousembolisma pages 5-6)
In veterinary neurology, fibrocartilaginous embolic myelopathy (FCEM) is a well-recognized cause of peracute noncompressive myelopathy in dogs/cats, with diagnosis definitively confirmed by histology showing fibrocartilaginous material in spinal vessels. (risio2010fibrocartilaginousembolicmyelopathy pages 6-8)
In a 2024 cohort of paraplegic dogs with thoracolumbar FCEM/ANNPE: - Deep pain positive: 9/14 (64.3%) regained independent ambulation - Deep pain negative: 1/12 (8.3%) regained independent ambulation - Deep pain negative status strongly predicted poor recovery (OR 47.40). (togawa2024outcomeinparaplegic pages 1-2)
These naturally occurring datasets support the central prognostic role of initial neurologic severity and can inform translational hypotheses, but they are not direct human clinical evidence. (togawa2024outcomeinparaplegic pages 1-2, risio2010fibrocartilaginousembolicmyelopathy pages 6-8)
No engineered genetic model organism systems were identified in the retrieved evidence. The most relevant “models” are naturally occurring veterinary FCEM cases and imaging/clinical cohorts, which provide translationally relevant ischemic myelopathy phenotypes and opportunities for biomarker and neuroprotection research. (risio2010fibrocartilaginousembolicmyelopathy pages 6-8, togawa2024outcomeinparaplegic pages 1-2)
References
(cuello2014acutecervicalmyelopathy pages 1-2): Juan P. Cuello, Santiago Ortega-Gutierrez, Guillermo Linares, Sachin Agarwal, Alyson Cunningham, Jay P. Mohr, Stephan A. Mayer, Randolph S. Marshall, Jan Claassen, Neeraj Badjatia, Mitchel S.V. Elkind, and Kiwon Lee. Acute cervical myelopathy due to presumed fibrocartilaginous embolism: a case report and systematic review of the literature. Journal of Spinal Disorders and Techniques, 27:E276–E281, Dec 2014. URL: https://doi.org/10.1097/bsd.0000000000000115, doi:10.1097/bsd.0000000000000115. This article has 18 citations.
(mateen2011clinicallysuspectedfibrocartilaginous pages 6-7): F. Mateen, F. Mateen, Priya Monrad, A. L. Hunderfund, Carrie E. Robertson, and E. J. Sorenson. Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes. European Journal of Neurology, 18:218-225, Feb 2011. URL: https://doi.org/10.1111/j.1468-1331.2010.03200.x, doi:10.1111/j.1468-1331.2010.03200.x. This article has 93 citations and is from a domain leading peer-reviewed journal.
(abdelrazek2016fibrocartilaginousembolisma pages 5-6): Mahmoud A. AbdelRazek, Ashkan Mowla, Salman Farooq, Nicholas Silvestri, Robert Sawyer, and Gil Wolfe. Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria. The Journal of Spinal Cord Medicine, 39:146-154, Feb 2016. URL: https://doi.org/10.1080/10790268.2015.1116726, doi:10.1080/10790268.2015.1116726. This article has 116 citations.
(taous2023spinalcordinfarction pages 1-2): Abdellah Taous, Taoufik Boubga, Tarik Boulahri, Soufiane Belabbes, Taoufik Africha, Omar Boulahroud, and Maha Ait Berri. Spinal cord infarction owing to likely fibrocartilaginous embolism. SAS Journal of Medicine, 9:1207-1209, Nov 2023. URL: https://doi.org/10.36347/sasjm.2023.v09i11.015, doi:10.36347/sasjm.2023.v09i11.015. This article has 0 citations.
(alfarsi2023spinalcordinfarct pages 2-4): Said A Al-Farsi, Haifa Al-Abri, Eiman Al-Ajmi, and Abdullah Al-Asmi. Spinal cord infarct due to fibrocartilaginous embolism in an adolescent boy: a case report and literature review. Cureus, Apr 2023. URL: https://doi.org/10.7759/cureus.37319, doi:10.7759/cureus.37319. This article has 7 citations.
(mateen2011clinicallysuspectedfibrocartilaginous pages 1-2): F. Mateen, F. Mateen, Priya Monrad, A. L. Hunderfund, Carrie E. Robertson, and E. J. Sorenson. Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes. European Journal of Neurology, 18:218-225, Feb 2011. URL: https://doi.org/10.1111/j.1468-1331.2010.03200.x, doi:10.1111/j.1468-1331.2010.03200.x. This article has 93 citations and is from a domain leading peer-reviewed journal.
(mateen2011clinicallysuspectedfibrocartilaginous pages 2-3): F. Mateen, F. Mateen, Priya Monrad, A. L. Hunderfund, Carrie E. Robertson, and E. J. Sorenson. Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes. European Journal of Neurology, 18:218-225, Feb 2011. URL: https://doi.org/10.1111/j.1468-1331.2010.03200.x, doi:10.1111/j.1468-1331.2010.03200.x. This article has 93 citations and is from a domain leading peer-reviewed journal.
(mateen2011clinicallysuspectedfibrocartilaginous pages 7-8): F. Mateen, F. Mateen, Priya Monrad, A. L. Hunderfund, Carrie E. Robertson, and E. J. Sorenson. Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes. European Journal of Neurology, 18:218-225, Feb 2011. URL: https://doi.org/10.1111/j.1468-1331.2010.03200.x, doi:10.1111/j.1468-1331.2010.03200.x. This article has 93 citations and is from a domain leading peer-reviewed journal.
(risio2010fibrocartilaginousembolicmyelopathy pages 6-8): Luisa De Risio and Simon R. Platt. Fibrocartilaginous embolic myelopathy in small animals. The Veterinary clinics of North America. Small animal practice, 40 5:859-69, Sep 2010. URL: https://doi.org/10.1016/j.cvsm.2010.05.003, doi:10.1016/j.cvsm.2010.05.003. This article has 121 citations.
(manara2010spinalcordinfarction pages 1-3): Renzo Manara, Milena Calderone, Maria Savina Severino, Valentina Citton, Irene Toldo, Anna Maria Laverda, and Stefano Sartori. Spinal cord infarction due to fibrocartilaginous embolization: the role of diffusion weighted imaging and short-tau inversion recovery sequences. Journal of Child Neurology, 25:1024-1028, Mar 2010. URL: https://doi.org/10.1177/0883073809355822, doi:10.1177/0883073809355822. This article has 34 citations and is from a peer-reviewed journal.
(manara2010spinalcordinfarction pages 3-4): Renzo Manara, Milena Calderone, Maria Savina Severino, Valentina Citton, Irene Toldo, Anna Maria Laverda, and Stefano Sartori. Spinal cord infarction due to fibrocartilaginous embolization: the role of diffusion weighted imaging and short-tau inversion recovery sequences. Journal of Child Neurology, 25:1024-1028, Mar 2010. URL: https://doi.org/10.1177/0883073809355822, doi:10.1177/0883073809355822. This article has 34 citations and is from a peer-reviewed journal.
(yamaguchi2019fibrocartilaginousembolismof pages 5-8): Hiroshi Yamaguchi, Hiroaki Nagase, Masahiro Nishiyama, Shoichi Tokumoto, Daisaku Toyoshima, Yoshinobu Akasaka, Azusa Maruyama, and Kazumoto Iijima. Fibrocartilaginous embolism of the spinal cord in children: a case report and review of literature. Pediatric neurology, 99:3-6, Oct 2019. URL: https://doi.org/10.1016/j.pediatrneurol.2019.04.013, doi:10.1016/j.pediatrneurol.2019.04.013. This article has 29 citations and is from a peer-reviewed journal.
(castello2023spinalcordinfarction pages 1-2): V. Ros Castelló, A. Sánchez Sánchez, E. Natera Villalba, A. Gómez López, P. Parra, F. Rodríguez Jorge, J. Buisán Catevilla, N. García Barragán, J. Masjuán, and Í. Corral. Spinal cord infarction: aetiology, imaging findings, and prognostic factors in a series of 41 patients. Neurología (English Edition), 38:391-398, Jul 2023. URL: https://doi.org/10.1016/j.nrleng.2020.11.004, doi:10.1016/j.nrleng.2020.11.004. This article has 20 citations.
(manara2010spinalcordinfarction pages 4-5): Renzo Manara, Milena Calderone, Maria Savina Severino, Valentina Citton, Irene Toldo, Anna Maria Laverda, and Stefano Sartori. Spinal cord infarction due to fibrocartilaginous embolization: the role of diffusion weighted imaging and short-tau inversion recovery sequences. Journal of Child Neurology, 25:1024-1028, Mar 2010. URL: https://doi.org/10.1177/0883073809355822, doi:10.1177/0883073809355822. This article has 34 citations and is from a peer-reviewed journal.
(castello2023spinalcordinfarction pages 5-7): V. Ros Castelló, A. Sánchez Sánchez, E. Natera Villalba, A. Gómez López, P. Parra, F. Rodríguez Jorge, J. Buisán Catevilla, N. García Barragán, J. Masjuán, and Í. Corral. Spinal cord infarction: aetiology, imaging findings, and prognostic factors in a series of 41 patients. Neurología (English Edition), 38:391-398, Jul 2023. URL: https://doi.org/10.1016/j.nrleng.2020.11.004, doi:10.1016/j.nrleng.2020.11.004. This article has 20 citations.
(mcbride2024nonsurgicalspinalcord pages 3-4): Fionán McBride, Jane Anketell, Gavin V. McDonnell, Suzanne Maguire, and Karen M. Doherty. Non-surgical spinal cord infarction: case series & long-term follow-up of functional outcome. Spinal Cord Series and Cases, Oct 2024. URL: https://doi.org/10.1038/s41394-024-00665-y, doi:10.1038/s41394-024-00665-y. This article has 1 citations and is from a peer-reviewed journal.
(NCT04372758 chunk 1): Descriptive Study of Acute Spontaneous Spinal Cord Infarction. University Hospital, Montpellier. 2020. ClinicalTrials.gov Identifier: NCT04372758
(abdelrazek2016fibrocartilaginousembolisma pages 1-2): Mahmoud A. AbdelRazek, Ashkan Mowla, Salman Farooq, Nicholas Silvestri, Robert Sawyer, and Gil Wolfe. Fibrocartilaginous embolism: a comprehensive review of an under-studied cause of spinal cord infarction and proposed diagnostic criteria. The Journal of Spinal Cord Medicine, 39:146-154, Feb 2016. URL: https://doi.org/10.1080/10790268.2015.1116726, doi:10.1080/10790268.2015.1116726. This article has 116 citations.
(togawa2024outcomeinparaplegic pages 1-2): Go Togawa, Melissa J. Lewis, and Dillon Devathasan. Outcome in paraplegic dogs with or without pain perception due to thoracolumbar fibrocartilaginous embolic myelopathy or acute non-compressive nucleus pulposus extrusion. Frontiers in Veterinary Science, May 2024. URL: https://doi.org/10.3389/fvets.2024.1406843, doi:10.3389/fvets.2024.1406843. This article has 7 citations and is from a peer-reviewed journal.
(zalewski2019characteristicsofspontaneous pages 3-4): Nicholas L. Zalewski, Alejandro A. Rabinstein, Karl N. Krecke, Robert D. Brown, Eelco F. M. Wijdicks, Brian G. Weinshenker, Timothy J. Kaufmann, Jonathan M. Morris, Allen J. Aksamit, J. D. Bartleson, Giuseppe Lanzino, Melissa M. Blessing, and Eoin P. Flanagan. Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria. JAMA Neurology, 76:56–63, Jan 2019. URL: https://doi.org/10.1001/jamaneurol.2018.2734, doi:10.1001/jamaneurol.2018.2734. This article has 249 citations and is from a highest quality peer-reviewed journal.
(zalewski2019characteristicsofspontaneous pages 1-2): Nicholas L. Zalewski, Alejandro A. Rabinstein, Karl N. Krecke, Robert D. Brown, Eelco F. M. Wijdicks, Brian G. Weinshenker, Timothy J. Kaufmann, Jonathan M. Morris, Allen J. Aksamit, J. D. Bartleson, Giuseppe Lanzino, Melissa M. Blessing, and Eoin P. Flanagan. Characteristics of spontaneous spinal cord infarction and proposed diagnostic criteria. JAMA Neurology, 76:56–63, Jan 2019. URL: https://doi.org/10.1001/jamaneurol.2018.2734, doi:10.1001/jamaneurol.2018.2734. This article has 249 citations and is from a highest quality peer-reviewed journal.
(chukwudelunzu2025fibrocartilaginousembolismspinala pages 2-3): FE Chukwudelunzu and T Young. Fibrocartilaginous embolism spinal cord infarction, mistaken for glial fibrillary acidic protein autoimmune transverse myelitis: a case report. Unknown journal, 2025.
(shah2018fibrocartilaginousemboliin pages 4-4): Supriya Shah and Phillip Bryant. Fibrocartilaginous emboli in the pediatric population: the role of rehabilitation in facilitating functional recovery. Journal of Pediatric Rehabilitation Medicine, 11:53-56, Mar 2018. URL: https://doi.org/10.3233/prm-170502, doi:10.3233/prm-170502. This article has 11 citations.
(fedaravicius2021successfulmanagementof pages 1-2): Augustinas Fedaravičius, Yael Feinstein, Isaac Lazar, Micky Gidon, Ilan Shelef, Elad Avraham, Arimantas Tamašauskas, and Israel Melamed. Successful management of spinal cord ischemia in a pediatric patient with fibrocartilaginous embolism: illustrative case. Journal of Neurosurgery: Case Lessons, Sep 2021. URL: https://doi.org/10.3171/case21380, doi:10.3171/case21380. This article has 5 citations.
(moore2018fibrocartilaginousembolicmyelopathy pages 1-2): Brittany J. Moore, Anna M. Batterson, Marianne T. Luetmer, and Ronald K. Reeves. Fibrocartilaginous embolic myelopathy: demographics, clinical presentation, and functional outcomes. Spinal Cord, 56:1144-1150, May 2018. URL: https://doi.org/10.1038/s41393-018-0159-y, doi:10.1038/s41393-018-0159-y. This article has 12 citations and is from a peer-reviewed journal.